11.32

1.43% 0.1485

Avita Medical Inc (RCEL)

Overview News Price History Option Chain Financials Why RCEL Down? Discussions Forecast Stock Split

Avita Medical Inc stock is traded at $11.32, with a volume of 35,129. It is up +1.43% in the last 24 hours and up +4.71% over the past month. Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Previous Close:

$11.17

Open:

$11.03

24h Volume:

35,129

Relative Volume:

0.31

Market Cap:

$294.20M

Revenue:

$50.14M

Net Income/Loss:

$-35.38M

P/E Ratio:

-9.2775

EPS:

-1.22

Net Cash Flow:

$-39.46M

1W Performance:

+9.68%

1M Performance:

+4.71%

6M Performance:

+29.49%

1Y Performance:

+5.89%

1-Day Range:

$11.03

$11.44

1-Week Range:

$10.05

$11.55

52-Week Range:

$7.51

$18.93

Avita Medical Inc Stock (RCEL) Company Profile

Name

Avita Medical Inc

Sector

Healthcare (1181)

Industry

Medical Devices (155)

Phone

661-568-1317

Address

28159 AVENUE STANFORD, VALENCIA, CA

Employee

207

Twitter

@AvitaMedical

Next Earnings Date

2024-11-07

Latest SEC Filings

RCEL's Discussions on Twitter

Avita Medical Inc Stock (RCEL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-27-23	Initiated	Cantor Fitzgerald	Overweight
Mar-02-21	Initiated	Piper Sandler	Overweight
Aug-27-20	Initiated	BofA Securities	Buy
Apr-21-20	Initiated	Oppenheimer	Outperform
Mar-03-20	Initiated	BTIG Research	Buy

Avita Medical Inc Stock (RCEL) Latest News

Nov 03, 2024

When (RCEL) Moves Investors should Listen - Stock Traders Daily

Nov 03, 2024

Oct 31, 2024

AVITA Medical (RCEL) to Release Quarterly Earnings on Thursday - Defense World

Oct 31, 2024

AVITA Medical (RCEL) Set to Announce Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2024

Oct 30, 2024

AVHHL (AVITA Medical) Net Income From Continuing Operations : $-49.83 Mil (TTM As of Jun. 2024) - GuruFocus.com

Oct 30, 2024

Oct 24, 2024

How the (RCEL) price action is used to our Advantage - Stock Traders Daily

Oct 24, 2024

Oct 21, 2024

The Manufacturers Life Insurance Company Invests $86,000 in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World

Oct 21, 2024

Oct 19, 2024

AQR Capital Management LLC Sells 67,535 Shares of AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat

Oct 19, 2024

Oct 17, 2024

Financial Analysis: AVITA Medical (NASDAQ:RCEL) & KORU Medical Systems (NASDAQ:KRMD) - Defense World

Oct 17, 2024

Oct 13, 2024

Essex Investment Management Co. LLC Invests $2.48 Million in AVITA Medical, Inc. (NASDAQ:RCEL) - MarketBeat

Oct 13, 2024

(RCEL) Long Term Investment Analysis - Stock Traders Daily

Oct 13, 2024

Oct 10, 2024

AVITA Medical to Announce Third Quarter 2024 Financial Results - ForexTV.com

Oct 10, 2024

AVITA Medical (NASDAQ:RCEL) shareholders have endured a 74% loss from investing in the stock five years ago - Yahoo Finance

Oct 10, 2024

Oct 08, 2024

These small cap ASX shares could rise 25% to 100% - The Motley Fool Australia

Oct 08, 2024

Oct 04, 2024

AVITA Medical, Inc.'s (NASDAQ:RCEL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - Simply Wall St

Oct 04, 2024

Oct 02, 2024